Coverage / PRTA / Trade Card

PRTA

Prothena Corporation PLC

OPPORTUNISTIC BUY 2026-08-01 Updated today USD 8.12 Healthcare - BiotechnologyAWAIT ENTRY
53

Position levels

Currenttoday
USD 8.12
Buy <=wait / entry
USD 6.83
Trim >=take some off
USD 9.50
Thesis breakTermination of the Roche birtamimab collaboration combined with a confirmed dilu...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case20%100 / 10020.0
Base case48%62 / 10029.8
Bear case32%10 / 1003.2
Weighted conviction53 / 100 - OPPORTUNISTIC BUY

Top risks

  • Q1 2026 EPS beat of $0.60 vs estimate of -$0.31
  • Next earnings report scheduled for 08/06/2026 with analyst EPS estimate of $0.23
  • Analyst consensus median price target of $20.00 with ratings of Buy 3 / Hold 2 / Sell 1
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.